Ad is loading...
ADNRX vs FSMAX
ADNRX vs FSMAX Comparison
Open Charts ADNRX vs FSMAX
American Beacon ARK Transfmt Innov R6
Price$12.89
Change-$0.15 (-1.15%)
VolumeN/A
CapitalizationN/A
Fidelity Extended Market Index
Price$86.79
Change-$0.63 (-0.72%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
VS
VS
ADNRX vs FSMAX Comparison Chart
Loading...
ADNRX vs. FSMAX commentary
Sep 21, 2024
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Sell and FSMAX is a StrongBuy.
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 41.9B vs. ADNRX (195M). FSMAX pays higher dividends than ADNRX: FSMAX (1.10) vs ADNRX (0.00). ADNRX was incepted earlier than FSMAX: ADNRX (4 years) vs FSMAX (13 years). ADNRX is a more actively managed with annual turnover of: 33.00 vs. FSMAX (18.00). ADNRX (0) and FSMAX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 28.78 vs. ADNRX (11.89).
| ADNRX | FSMAX | ADNRX / FSMAX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 4 years | 13 years | - |
| Gain YTD | -11.560 | 11.184 | -103% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 195M | 41.9B | 0% |
| Annual Yield % from dividends | 0.00 | 1.10 | - |
| Returns for 1 year | 11.89 | 28.78 | 41% |
| Returns for 3 years | -71.65 | 1.47 | -4,886% |
| Returns for 5 years | N/A | 45.86 | - |
| Returns for 10 years | N/A | 76.52 | - |
View a ticker or compare two or three
VS
VS
Ad is loading...